000 01300 a2200349 4500
005 20250515195105.0
264 0 _c20100204
008 201002s 0 0 eng d
022 _a1744-8379
024 7 _a10.1586/erp.09.62
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLloyd, Andrew
245 0 0 _aReimbursement agency requirements for health related quality-of-life data: a case study.
_h[electronic resource]
260 _bExpert review of pharmacoeconomics & outcomes research
_cDec 2009
300 _a527-37 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review; Systematic Review
650 0 4 _aAtrial Fibrillation
_xeconomics
650 0 4 _aDecision Making
650 0 4 _aGuidelines as Topic
650 0 4 _aHumans
650 0 4 _aModels, Economic
650 0 4 _aQuality of Life
650 0 4 _aQuality-Adjusted Life Years
650 0 4 _aReimbursement Mechanisms
650 0 4 _aStroke
_xeconomics
650 0 4 _aTechnology Assessment, Biomedical
_xmethods
700 1 _aWild, Diane
700 1 _aGallop, Katy
700 1 _aCowell, Warren
773 0 _tExpert review of pharmacoeconomics & outcomes research
_gvol. 9
_gno. 6
_gp. 527-37
856 4 0 _uhttps://doi.org/10.1586/erp.09.62
_zAvailable from publisher's website
999 _c19325295
_d19325295